FR2991580A1 - RINSE COMPOSITION COMPRISING A FILMOGENEOUS POLYMER - Google Patents

Abstract

The invention relates to a foaming cleansing cosmetic composition comprising, in a physiologically acceptable medium: - a surfactant system with an active ingredient content greater than or equal to 3% by weight, relative to the total weight of the composition, - at least one suspending agent, - at least one cosmetic additive, - at least one water-insoluble, copolymer-type, film-forming polymer comprising at least one monomer unit of the acrylate type, said polymer particles having a primary size of number greater than 500 nm. It also relates to a method for cleaning keratinous materials comprising applying said composition to said keratinous materials, then foaming and then rinsing said composition.

Description

The present invention relates to a foaming cosmetic composition to be rinsed containing at least one cosmetic additive and a water-insoluble adhesive polymer of the copolymer type comprising at least one monomeric unit of the acrylate type, allowing the deposition of said at least one cosmetic additive on keratin materials.

The deposition of cosmetic additives on keratin materials is known in non-rinsed condition. However, such a deposit can be sought through cleaning products. Thus, the consumer may be looking for additional perceptible effects such as brightness of the complexion, whitening, matting or hydration of the skin, or sensory properties such as softness.

Some loads, because of their physico-chemical properties (refractive index, color, oil absorption, ...) are actually used in these axes in non-rinsed conditions. However, the deposition of charges or active ingredients on keratin materials is very low after the use of a cleaning product and its rinsing. To date some technical solutions have been proposed, which can be summarized as follows: the use of cationic compounds such as polymers, surfactants and cationic particles, which causes a compatibility problem in anionic formulations, or the use of an emulsified oil as a particle deposition agent, this type of oil often having as an undesirable effect an anti-foaming character. Therefore, there is a need to provide foaming cleansing compositions without the aforementioned disadvantages. The inventors have demonstrated that the combination in a foaming cleaning composition of at least one cosmetic additive with a copolymer-type water-insoluble adhesive polymer comprising at least one monomeric unit of the acrylate type enables a deposit to be made. on the keratin materials of said at least one cosmetic additive, without deteriorating the foaming capacity of the composition. The subject of the present invention is thus a foaming cleansing cosmetic composition to be rinsed comprising, in a physiologically acceptable medium: a surfactant system with an active material content greater than or equal to 3% by weight, relative to the total weight of the composition at least one suspending agent, at least one cosmetic additive, and at least one film-forming, water-insoluble, copolymer-type polymer having at least one acrylate-type monomer unit, said polymer particles having a primary size greater than 500 nm.

For the purposes of the present invention, the term "primary particle size" means the maximum dimension that can be measured between two diametrically opposite points of an individual particle. It is understood that, in the case of a population of particles of different sizes, the size indicated corresponds to the average size in number of the population.

In the description that follows, "size" is understood to mean "primary size in number". The size can be determined by transmission electron microscopy or from the measurement of the specific surface area by the BET method or from a laser granulometry.

Against all expectations, the inventors have found that the use of this cosmetic composition makes it possible to deposit at least one cosmetic additive on the keratin materials, whereas the composition is deposited, spread on the keratin materials, foamed in order to use its cleaning properties and rinse with water.

The invention, according to another of its aspects, also relates to a process for cleaning keratinous substances comprising applying to said keratin materials a composition according to the invention, to foam said composition and then rinsing said composition, in particular to 'water. The subject of the present invention is also the cosmetic use of the composition as defined above, for removing makeup and / or cleaning the skin, the hair and / or the mucous membranes, or the care of the skin. For the purposes of the present invention, the term "physiologically acceptable medium" means a medium suitable for the administration of a composition topically.

A physiologically acceptable medium is preferably a cosmetically or dermatologically acceptable medium, that is to say without odor, or unpleasant appearance, and which is perfectly compatible with the topical route of administration.

Such a medium is particularly considered physiologically acceptable when it does not generate tingling, tightness or redness unacceptable to the user. The compositions of the invention are compositions for rinsing (rinsing with water or with a tonic), and they can be used in the field of cleansing of the cleansing of the skin of the face or body, of the hair including the scalp, and mucous membranes such as the lips. They may also constitute skincare products such as masks to rinse (in the usual way of using these products).

COSMETIC ADDITIVES The cosmetic additives that may be included in the composition according to the present invention may in particular be particles, fibers and / or active ingredients and mixtures thereof.

For the purpose of the present invention, a "cosmetic additive" is a compound intended to confer a cosmetic property that may for example be chosen from: a contribution of color, a modification of texture, a sunscreen, an improvement of the hold, a hydration skin, etc. Among the particles that may be included in the composition according to the present invention, mention may be made of: organic pigments. Among the organic pigments, mention may be made of carbon black, D & C type pigments, and lacquers based on cochineal carmine, barium, strontium, calcium, aluminum. inorganic pigments such as: o titanium oxide, zinc oxide, colored iron oxide, o alumina, o pearlescent agents, o carbonates, o ceramic particles, for example nitride boron, o diamond / graphite, o magnesia, o glass such as boro and phosphosilicate, o silica such as amorphous silica, colloidal, precipitated, fumed, natural or in the form of silica-gels, o clay such as, for example, monmorionite, zirconium and barium sulphate, silicates such as, for example, talc, illite, kaolin, zeolite, sepiolite, laponite, hectorite, bentonite, mica, or Lionite PC particles marketed by Lion Corporation based on silica, ZnO, Al 2 O 3 and TiO 2, polymer particles such as, for example, polymethyl methacrylate (PMMA) particles, polytetrafluoroethylene (PTFE) particles, of polyamide, polyacrylate or their copolymers, the particles of wax such as, for example, carnauba wax, inorganic sunscreen particles such as, for example, TiO 2, perlite particles, silica airgel particles, and mixtures thereof. The particles may also be oil globules in the form of an emulsion.

All the particles mentioned above can be sought for various purposes such as imparting color, different types of glare, softness, dullness, changing the texture of the skin, providing protection to the skin, especially solar . According to a particular embodiment of the present invention, the particles have a size of less than 1 mm, preferably less than 100 μm and more preferably less than 30 μm. Among the fibers that can be included in the composition according to the present invention, mention may be made, for example, of polyamide or nylon fibers, polyaramid, viscose, cotton, polyacrylic, polyvinyl acetate or PVA or fibers. 30 composites.

Among the active agents that can be included in the composition according to the present invention, mention may be made of vitamins, such as, for example, vitamins A, B3, PP, B5, E, K1 and / or C and the derivatives of these vitamins and in particular their esters; keratolytic agents or prodesquamants, for example hydroxy-acids, hydroxy acids, ketoacids, -ceto-acids, retinoids and their esters, retinal, retinoic acid and its derivatives; plant extracts such as extracts of small holly and / or horse chestnut; xanthine bases such as caffeine; anti-free radical agents; organic or inorganic sunscreens; moisturizing agents such as polyols; ceramides; DHEA and its derivatives; coenzyme Q10; bleaching and depigmenting agents by biological action such as kojic acid, extracts of skullcap, mulberry, licorice and / or chamomile; para-aminophenol derivatives, arbutin and derivatives thereof, bacterial anti-adhesion active agents such as salicylic acid and capryloyl salicylic acid, and mixtures thereof. For use in the cosmetic treatment of oily or combination skin, the composition according to the invention may contain in particular at least one antiseborrhoeic active agent chosen from vitamins B3 and B5; zinc salts, and in particular zinc oxide and zinc gluconate; salicylic acid and its derivatives such as noctanoyl-5-salicylic acid; triclosan; capryloylglycine; an extract of clove; octopirox; hexamidine; azelaic acid and its derivatives.

According to a particular embodiment, the active agents according to the invention may be carried in cage molecules of the cyclodextrin, niosome or liposome type. In the event of incompatibility or to stabilize them, the above-mentioned active agents may be incorporated into spherules, in particular ionic or nonionic vesicles and / or nanoparticles (nanocapsules and / or nanospheres). The composition may include both particles, fibers and actives. In this case, the content considered of said at least one cosmetic additive is that of particles, fibers and active ingredients, taken in their entirety.

Said at least one cosmetic additive may be included in the composition according to the present invention in an active material content of between 0.1 and 10% by weight, in particular between 0.1 and 5% by weight, relative to the total weight of the composition. COPOLYMER ACRYLATE The composition according to the invention comprises at least one film-forming polymer in the form of particles, which is insoluble in water, of copolymer type comprising at least one monomeric unit of acrylate type, said polymer particles having a size greater than 500 nm. By "film-forming" polymer is meant a polymer capable of forming, by itself or in the presence of an auxiliary film-forming agent, a macroscopically continuous film on a support, in particular on keratin materials, and preferably a cohesive film. Said at least one film-forming polymer is capable of fixing particles on the skin, remanently to induce visible effects without having a negative impact on the foam properties of the composition according to the invention.

The at least one film-forming polymer according to the invention is adhesive. According to a particular embodiment of the invention, the particle size of said at least one film-forming polymer is greater than 500 μm, preferably 500 nm to 200 μm, more preferably 500 nm to 50 μm, and even more preferentially from 1 to 40 gm.

The at least one film-forming polymer may be included in the composition according to the present invention in an active material content ranging from 0.1 to 20% by weight, in particular from 0.1 to 5% by weight, relative to the total weight. of the composition. According to a particular embodiment of the invention, said at least one film-forming polymer has a glass transition temperature (Tg) less than or equal to 10 ° C. The glass transition temperature (Tg) of said at least one film-forming polymer according to the present invention can be measured by differential scanning calorimetry (DSC) under the following conditions: To measure the glass transition temperature a film having a thickness of about 150 mm of the polymer to be tested is made by depositing an aqueous solution or dispersion of the polymer in a teflon circular matrix 40 mm in diameter and allowing the deposit to dry. The film is allowed to dry in an oven at a temperature of about 23 ° C under a relative humidity of 45%, until the weight no longer varies. About 5 to 15 mg of the film are taken and placed in a crucible which is then introduced into the analyzer. The thermal analyzer is a model DSC-2920 from the company TA INSTRUMENTS. The initial and final temperatures of the temperature sweep are chosen so as to frame the desired glass transition temperature. The temperature sweep is at a rate of 10 ° C / minute. This analysis is carried out according to ASTM D3418-97 with the modifications above. Said at least one film-forming polymer according to the invention preferably has a self-adhesiveness such that the tensile force (Fmax in Newton (N)) necessary to separate two coated surfaces of said polymer is greater than 1 N and preferably greater than 1 N. 3 N. The tensile force Fmax can be measured under the following conditions using an extensometer: two rigid, inert, non-absorbent glass supports (A) and (B) each having a surface area of 0.95 cm2 , are coated with a polymer layer to be tested. The polymer is deposited from a 10% solids concentration (C) coating composition (in grams per 100 grams of composition) in a suitable solvent, and the surfaces of the supports are coated at a rate of 4%. C mg / cm2. After evaporation of the said solvent for 24 hours at 22 ° C. under a relative humidity of 50%, the two coated surfaces of the disks are superimposed and the supports pressed against each other for 20 seconds at a pressure of 3 N at using an LLOYD model LR5K extensometer. The glued supports are then pulled away from one another at a speed of 20 mm / minute and the pulling force is continuously recorded. The maximum tensile force, recorded at the time of the separation of the two surfaces, called Fmax, characterizes the self-adhesive nature of the polymer. The greater this force, the greater the self-adhesive nature of the polymer.

According to one particular embodiment, the film-forming polymers according to the invention, in particular of formulas (I), (II), (I ') and (II') defined below, or the film-forming polymers described more specifically after have a weight average molecular weight of between 50,000 and 200,000 g / mol, more particularly between 100,000 and 200,000 g / mol, more preferably 110,000 and 180,000 g / mol. According to a first particular embodiment of the invention, said at least one film-forming polymer comprises at least one monomeric unit of alkylacrylamide type. According to a particular embodiment of the invention, said at least one film-forming polymer comprises at least the following two monomeric units represented by the general formulas (A) and (B): ## STR2 ## (B) wherein R1 R2 and R3 are represented by a hydrogen atom or a (C1-C50) alkyl group, preferably (C1-C20) alkyl. More particularly, said monomer units may be connected to each other according to the following general formula (I): ## STR1 ## wherein x and z are independently of each other whole numbers greater than or equal to Preferably, said polymer comprises at least the following three monomeric units represented by the general formulas (A), (B) and (C): CO2Ri * R2 (A) * C * H2 2H (C) H2 (B) ) in which R1 R2 and R3 are represented by a hydrogen atom or a (C1-C50) alkyl group, preferably (C1-C20) alkyl. More particularly, said monomeric units may be connected to each other according to the following general formula (II): ## STR2 ## wherein x, y and z are independently of each other whole numbers greater than or equal to According to a particular embodiment of the invention, said at least one film-forming polymer is of the acrylate (s) / octylacrylamide copolymer type. Thus, according to one particular embodiment of the invention, said at least one film-forming polymer comprises at least the following two monomeric units represented by the general formulas (A) and (B '): ## STR2 ## 2) H 2 (B ') R 2 (A) wherein R 1 and R 2 are represented by a hydrogen atom or a (C 1 -C 50) alkyl, preferably (C 1 -C 20) alkyl group, more particularly said units monomers can be connected to each other according to the following general formula (I '): ## STR1 ## in which which x and z are independently of one another integers greater than or equal to 1.

Preferably, said polymer comprises at least the following three monomeric units represented by the general formulas (A), (B ') and (C): (V), CO2Ri CH3 (B') * C * H3C CH3 H2 é02H (C) ) In which R1 and R2 are represented by a hydrogen atom or a (C1-C50) alkyl group, preferably (C1-C20) alkyl group.

More particularly, said monomeric units may be connected to one another according to the following general formula (II '): ## STR2 ## in which x, y and z are independently of each other whole numbers greater than or equal to 1. According to a particular embodiment of the invention, said at least one film-forming polymer is an octylacrylamide / acrylate type copolymer or an octylacrylamide / type copolymer. acrylate / butylaminoethyl / methacrylate. Among the copolymers of octylacrylamide / acrylate type according to the invention, there may be mentioned "Dermacryl 79" from the company AKZO NOBEL of general formula (III) which follows. (III) "Dermacryl 79" has a weight average molecular weight of between 120,000 and 170,000 g / mol. It is in the form of beads of approximately 10 μm at acidic pH which swell during the neutralization. Among the copolymers of octylacrylamide / acrylates / butylaminoethyl methacrylate type according to the invention, mention may also be made of "Amphomer LV71" from Akzo Nobel, which is formed from octylacrylamide, t-butylaminoethyl methacrylate and at least two monomers of acrylic acid, methacrylic acid or one of their esters. According to a second particular embodiment of the invention, said at least one film-forming polymer is a copolymer consisting of at least two monomeric units of different acrylate type. For the purposes of the invention, the term "monomeric unit of acrylate type" means the monomeric unit (A) shown above. By "two different acrylate-type monomeric units" is meant two acrylate-type units in which at least one of R1 and R2 has a different meaning in these two monomeric units. The film-forming polymers according to the invention comprising an acid function may be deprotonated with a suitable base such as potassium hydroxide in order to reduce the amount of the acid-forming polymers. be soluble in water.

SUSPENSION AGENT The suspending agents function to gel or thicken the compositions and to prevent sedimentation of the particles present in the cleaning product according to the present invention. The suspending agents can be of natural origin. They can then be selected from xanthan, carrageenan, guar and starch. The suspending agents can be of synthetic origin. They can then be chosen from the following products aculyn 38 (CTFA name: ACRYLATES / VINYL NEODECANOATE CROSSPOLYMER) marketed by Rôhm & Haas, Aqua SF1 (slightly crosslinked acrylic polymer) marketed by Lubrizol or, more generally, Carbopol® family products marketed by Lubrizol . The suspending agent may be included in the composition according to the present invention in an active material content of between 0.1 and 10% by weight, in particular between 0.1 and 2.5% by weight, relative to the weight total of the composition.

Foaming Surfactant The foaming composition according to the invention contains a surfactant system which will bring the foaming character to the composition. Said surfactant system may consist of one or more surfactants. Foaming surfactants are detergents and differ from emulsifiers by the value of their HLB (Hydrophilic Lipophilic Balance), the HLB being the ratio between the hydrophilic part and the lipophilic part in the molecule. The term HLB is well known to those skilled in the art and is described, for example, in "The HLB system." (Published by ICI Americas Inc., 1984). For emulsifiers, the HLB generally ranges from 3 to 8 for the preparation of W / O emulsions and from 8 to 18 for the preparation of O / W emulsions, whereas the foaming surfactants generally have an HLB greater than 20.

The composition according to the present invention comprises a surfactant system with an active ingredient content of greater than 3% by weight, relative to the total weight of the composition, preferably greater than 5% by weight, more preferably greater than 10%. in weight.

The surfactants are preferably selected from anionic, amphoteric (or zwitterionic), nonionic and / or cationic foaming surfactants and mixtures thereof. Anionic Surfactants The anionic surfactants that may be present in the composition according to the invention may be chosen in particular from anionic derivatives of proteins of plant origin or silk proteins, phosphates and alkylphosphates, carboxylates, sulphosuccinates and amino acid derivatives. alkyl sulphates, alkyl ether sulphates, sulphonates, isethionates, taurates, alkyl sulphoacetates, polypeptides, anionic alkyl polyglucoside derivatives, soaps (fatty acid salts) and mixtures thereof. a) The anionic derivatives of proteins of vegetable origin are hydrolysates of protein with a hydrophobic group, said hydrophobic group possibly being naturally present in the protein or being added by reaction of the protein and / or the protein hydrolyzate with a compound hydrophobic. The proteins are of plant origin or silk derivatives, and the hydrophobic group may be in particular a fatty chain, for example an alkyl chain comprising from 10 to 22 carbon atoms. As anionic derivatives of proteins of vegetable origin, mention may be made more particularly of the hydrolysates of apple, wheat, soy, and oat proteins, comprising an alkyl chain having from 10 to 22 carbon atoms and their salts. The alkyl chain may in particular be a lauryl chain and the salt may be a salt of sodium, potassium and / or ammonium. Thus, as hydrolysates of protein with a hydrophobic group, there may be mentioned, for example, the salts of lauric acid-modified silk protein hydrolysates, such as the product marketed under the name KAWA Silk by the company Kawaken; salts of hydrolysates of wheat protein modified with lauric acid, such as the potassium salt marketed under the name Aminofoam W OR by the company Croda (CTFA name: Potassium lauroyl wheat aminoacids) and the sodium salt marketed under the name PROTEOL LW 30 by the company Seppic (CTFA name: sodium lauroyl wheat aminoacids); salts of oat protein hydrolysates having an alkyl chain having from 10 to 22 carbon atoms, and more particularly salts of lauric acid modified oat protein hydrolysates, such as the sodium salt marketed under PROTEOL OAT designation (30% aqueous solution) by the company Seppic (CTFA name: Sodium lauroyl oat aminoacids); salts of apple protein hydrolysates, comprising an alkyl chain having from 10 to 22 carbon atoms, such as the sodium salt sold under the name PROTEOL APL (30% hydrogen glycolic solution) by the company Seppic (CTFA name: Sodium Cocoyl Apple amino acids). Mention may also be made of the mixture of lauroyl amino acids (aspartic, glutamic, glycine, alanine) neutralized with sodium N-methylglycinate, sold under the name PROTEOL SAV 50 S by the company Seppic (CTFA name: Sodium Cocoyl amino acids). b) Phosphates and alkylphosphates include, for example, monoalkyl phosphates and dialkyl phosphates, such as lauryl mono-phosphate sold under the name MAP 20® by the company Kao Chemicals, the potassium salt of dodecyl acid, phosphoric acid, a mixture of mono- and di-ester (majority diester) marketed under the name CRAFOL AP-3 1® by the company Cognis, the mixture of monoester and octylphosphoric acid di-ester, sold under the name CRAFOL AP- 20® by the company Cognis, the mixture of monoester and ethoxylated 2-butyloctanol phophoric acid diester (7 moles of EO), sold under the name ISOFOL 12 7 EO-PHOSPHATE ESTER® by Condea, salt potassium or triethanolamine monoalkyl (C12-C13) phosphate sold under the references ARLATONE MAP 230K-40® and ARLATONE MAP 230T-600 by the company Uniqema, potassium lauryl phosphate marketed penny s the name DERMALCARE MAP XC-99 / 09® by the company Rhodia Chimie, and the potassium cetylphosphate marketed under the name ARLATONE MAP 160K by the company Uniqema. c) As carboxylates, mention may be made of: amido ether carboxylates (AEC), such as sodium lauryl amido ether carboxylate (30E), sold under the name AKYPO FOAM 30® by the company Kao Chemicals, -the acid salts polyoxyethylenated carboxylic acids, such as sodium lauryl ether carboxylate (C12-14-16 65/25/10) oxyethylenated (60E) sold under the name AKYPO SOFT 45 NV® by Kao Chemicals, fatty acids of oil origin polyoxyethylenated and carboxymethylated olive oils sold under the name OLIVEM 400e by the company BIOLOGIA E TECNOLOGIA, the oxyethylenated tri-decyl ether carboxylate (60E) sold under the name NIKKOL ECTD-6NEX® by the company Nikkol, -the salts of fatty acids (soaps) having a C6 to C22 alkyl chain, neutralized with an organic or inorganic base such as potassium hydroxide, sodium hydroxide, triethanolamine, N-methylglucamine, lysine and arginine. d) Amino acid derivatives that may be mentioned include, in particular, alkaline salts of amino acids, such as: sarcosinates, such as sodium Lauroyl sarcosinate sold under the name SARKOSYL NL 97® by the company Ciba or marketed under the name ORAMIX L 30® by the company Seppic, the sodium myristoyl sarcosinate sold under the name NIKKOL SARCOSINATE MN® by the company Nikkol, the sodium palmitoyl sarcosinate sold under the name NIKKOL SARCOSINATE PN® by the company Nikkol, the alaninates, as the sodium N-lauroyl-N sodium amidopropionate sold under the name Sodium Nikol alkanate LN 30® by the company Nikkol or marketed under the name Alanone Ale® by the company Kawaken 25, the N-lauroyl N-methyl alanine triethanolamine marketed under the name ALANONE ALTA ® by the company Kawaken, - Glutamates, as the mono-cocoyl glutamate sorted thanolamine sold under the name ACYLGLUTAMATE CT-12® by the company Ajinomoto, triethanolamine lauroylglutamate marketed under the name ACYLGLUTAMATE LT-12® by the company Ajinomoto, aspartates, such as the mixture of N-lauroyl aspartate of triethanolamine / N -myristoyl triethanolamine aspartate sold under the name ASPARACK® by Mitsubishi; -glycine derivatives (glycinates), such as sodium N-cocoyl glycinate sold under the names Amilite GCS-12® and Amilite GCK 12 by the company Ajinomoto, Citrates such as the mono-citric ester of oxyethylenated coconut alcohols (9 moles), sold under the name WITCONOL EC 1129 by the company Goldschmidt, 10-galacturonates such as the marketed sodium dodecyl d-galactoside uronate by the company Soliance. e) As sulfosuccinates, there may be mentioned, for example, the oxyethylenated (30E) lauryl alcohol (C12 / C14 70/30) monosulphosuccinate marketed under the trade names SETACIN 103 SPECIAL®, REWOPOL SB-FA 30 K 4® by the Witco company, the di-sodium salt of a hemi-sulfosuccinate of C12-C14 alcohols, sold under the name SETACIN F SPECIAL PASTE® by the company Zschimmer Schwarz, the di-sodium oxyethylenated oleamide sulfosuccinate (20E) marketed under the name STANDAPOL SH 135® name by the company Cognis, the oxyethylenated lauric amide mono-sulfosuccinate (50E) sold under the name LEBON A-5000® by the company Sanyo, the di-sodium salt of lauryl citrate monosulfosuccinate oxyethylenated (10 OE) marketed under the name REWOPOL SB CS 50® by the company Witco, ricinoleic mono-ethanolamide mono-sulfosuccinate sold under the name REWODERM S 1333® by the company Witco. It is also possible to use polydimethylsiloxane sulphosuccinates such as disodium PEG-12 dimethicone sulphosuccinate sold under the name MACKANATE-DC30 by the company Mac Intyre. f) As alkyl sulphates, mention may be made, for example, of triethanolamine lauryl sulphate (CTFA name: TEA-lauryl sulphate), such as the product marketed by Huntsman under the name EMPICOL TL40 FL or that marketed by Cognis on the French market. TEXAPON T42 denomination, products which are 40% in aqueous solution. It is also possible to mention ammonium lauryl sulphate (CFTA name: Ammonium lauryl sulphate), such as the product marketed by Huntsman under the name EMPICOL AL 30FL which is 30% in aqueous solution. g) As alkyl ether sulphates, mention may be made, for example, of sodium lauryl ether sulphate (CTFA name: sodium laureth sulfate), such as that marketed under the names TEXAPON N40 and TEXAPON AOS 225 UP by the company Cognis, lauryl ether sulphate. ammonium (CTFA name: ammonium laureth sulfate) such as that marketed under the name Standapol EA-2 by Cognis. h) As sulphonates, mention may be made, for example, of alpha-olefin sulphonates, such as sodium alpha-olefin sulphonate (C14-16) sold under the name BIO-TERGE AS-40® by the company Stepan, marketed under the names WITCONATE AOS PROTEGE® and SULFRAMINE AOS PH 12® by the company Witco or sold under the name BIO-TERGE AS-40 CG® by Stepan, the secondary sodium olefin sulfonate sold under the name Hostapur SAS 30® by the company Clariant ; linear alkyl aryl sulphonates, such as sodium xylene sulphonate sold under the names MANROSOL SXS3O®, MANROSOL SXS40®, MANROSOL SXS93® by the company Manro. i) As isethionates, mention may be made of acylisethionates such as sodium cocoylisethionate, such as the product sold under the name JORDAPON CI P® by the company Jordan. j) As taurates, mention may be made of the sodium salt of palm kernel oil methyltaurate marketed under the name HOSTAPON CT PATE® by the company Clariant; N-acyl N-methyltaurates, such as the sodium N-cocoyl N-methyltaurate sold under the name HOSTAPON LT-SFO by the company Clariant or marketed under the trademark NIKKOL CMT-30-T® by the company Nikkol, palmitoyl methyltaurate, sodium marketed under the name NIKKOL PMT® by Nikkol. k) The anionic derivatives of alkyl polyglucosides can be in particular citrates, tartrates, sulfosuccinates, carbonates and glycerol ethers obtained from the alkyl polyglucosides. Mention may be made, for example, of the sodium salt of cocoylpolyglucoside (1,4) tartaric ester, sold under the name EUCAROL AGE-ET® by the company Cesalpinia, the sodium salt of cocoylpolyglucoside sulfosuccinic ester (1,4). ), marketed under the name ESSAI 512 MP® by the company Seppic, the sodium salt of citric ester cocoyl polyglucoside (1,4) sold under the name EUCAROL AGE-ECe by Cesalpinia. 1) Soaps are obtained from a fatty acid that is partially or totally saponified (neutralized) with a basic agent. These are alkali or alkaline-earth metal soaps or organic bases. As fatty acids, it is possible to use saturated, linear or branched fatty acids containing from 8 to 30 carbon atoms, and preferably containing from 8 to 22 carbon atoms. This fatty acid may in particular be chosen from palmitic acid, stearic acid, myristic acid, auric acid and mixtures thereof.

As basic agents, it is possible to use, for example, alkali metal hydroxides (sodium hydroxide and potassium hydroxide or potassium hydroxide), alkaline earth metal hydroxides (for example magnesium), ammonium hydroxide, or even organic bases such as triethanolamine, N-methylglucamine, lysine and arginine.

The soaps may be in particular alkali salts of fatty acid, the basic agent being an alkali metal hydroxide, and preferably potassium hydroxide or potassium hydroxide (KOH). The amount of basic agent must be sufficient for the fatty acid to be at least partially neutralized.

Preferably, the anionic surfactant is chosen from alkyl sulphates, alkyl ether sulphates such as sodium lauryl ether sulphate, isethionates and amino acid derivatives, in particular glycine derivatives (glycinates), such as N-cocoyl glycinate. sodium and mixtures thereof.

Amphoteric and Zwitterionic Foaming Surfactants The amphoteric and zwitterionic surfactants may be chosen for example from betaines, N-alkylamidobetaines and their derivatives, sultaines, alkyl polyaminocarboxylates, alkylamphoacetates and mixtures thereof. As betaines, mention may be made in particular of alkyl betaines such as, for example, cocobetaine, such as the product sold under the name Dehyton AB-30e by the company Cognis, lauryl betaine, and the product sold under the name GENAGEN KBe by the company Clariant, and lauryl betaine, which is oxyethylenated. (10 OE), such as the product sold under the name LAURYLETHER (10 OE) BETAINE® by the company Shin Nihon Rica, stearyl betaine oxyethylenated (10 OE) as the product sold under the name STEARYLETHER (10 OE) BETAINE® by the company Shin Nihon Rica.

Among the N-alkylamidobetaines and their derivatives, mention may be made, for example, of cocamidopropyl betaine marketed under the name LEBON 2000 HG® by the company Sanyo, or marketed under the name EMPIGEN BB® by the company Albright & Wilson, lauramidopropyl betaine marketed under the name REWOTERIC AMB12P® by the company Witco.

As sultaines, mention may be made of hydroxylsultaines, such as cocamidopropyl hydroxysultaine such as the product sold under the name REWOTERIC AM CAS by the company Golschmidt-Degussa, or the product marketed under the name CROSULTAINE C-50® by the company Croda. As alkyl polyaminocarboxylates (APAC), there may be mentioned sodium cocoylpolyamino carboxylate, sold under the name AMPHOLAK 7 CX / C®, and AMPHOLAK 7 cxe by Akzo Nobel, the sodium stearylpolyamidocarboxylate sold under the name AMPHOLAK 7 TX / C by Akzo Nobel, sodium carboxymethylolpropylamine, marketed under the name AMPHOLAK X07 / C® by Akzo Nobel.

As alkylamphoacetates, mention may be made, for example, of N-cocoyl-N-carboxymethoxyethyl-N-carboxymethyl-ethylenediamine N-di-sodium (CTFA name: disodium cocoamphodiacetate), such as the product marketed under the name MIRANOL C2M CONCENTRA NPO by Rhodia, N-cocoyl-N-hydroxyethyl-N-carboxymethyl-ethylenediamine N-sodium (CTFA name: sodium cocamphoacetate), sodium cocoamphohydroxypropyl sulfonate sold under the name MIRANOL CSE by Rhodia. Preferably, the amphoteric or zwitterionic surfactant is chosen from betaines, and especially alkylbetaines, alkylamphoacetates, such as sodium cocamphoacetate, and mixtures thereof. Nonionic foaming surfactant Nonionic foaming surfactants that may be present in the composition of the invention may be chosen in particular from alkyl polyglucosides (APG), oxyalkylenated glycerol esters, oxyalkylenated sugar esters, and mixtures thereof. These are preferably APGs. Preferred alkylpolyglucosides are those containing an alkyl group having 6 to 30 carbon atoms and preferably 8 to 16 carbon atoms, and containing a glucoside group preferably comprising 1.2 to 3 glucoside units. The alkylpolyglucosides may be chosen for example from decylglucoside (Alkyl-C9 / Cl-polyglucoside (1.4)) such as the product marketed under the name Mydol 10® by the company Kao Chemicals or the product marketed under the name Plantacare 2000 UP® by the Cognis company; caprylyl / capryl glucoside, such as the product marketed under the name Plantacare KE 3711® by the company Cognis; laurylglucoside, such as the product marketed under the name Plantacare 1200 UP® by the company Cognis; cocoglucoside as the product marketed under the name Plantacare 818 upe by Cognis; caprylylglucoside as the product marketed under the name Plantacare 810 upe by Cognis; and their mixtures. The oxyalkylenated glycerol esters are in particular the polyoxyethylenated derivatives of glyceryl and fatty acid esters and their hydrogenated derivatives. These oxyalkylenated glycerol esters may be chosen, for example, from glyceryl esters of hydrogenated and oxyethylenated fatty acids, such as PEG-200 hydrogenated glyceryl palmate sold under the name Rewoderm LI-S 80 by the company Goldschmidt; oxyethylenated glyceryl cocoates such as PEG-7 glyceryl cocoate sold under the name Tegosoft GC by the company Goldschmidt, and PEG30 glyceryl cocoate sold under the name Rewoderm LI-63 by the company Goldschmidt; and their mixtures. The oxyalkylenated sugar esters are in particular the polyethylene glycol ethers of the fatty acid and sugar esters. These oxyalkylenated sugar esters may be chosen for example from oxyethylenated glucose esters such as PEG-120 methyl glucose dioleate sold under the name Glucamate DOE 120 by the company Amerchol.

According to a preferred embodiment of the invention, the nonionic surfactant is an alkylpolyglucoside which may be chosen in particular from decylglucoside, caprylyl / capryl glucoside, laurylglucoside, cocoglucoside, caprylylglucoside, and mixtures thereof.

Cationic foaming surfactant According to one embodiment, the composition according to the invention may comprise at least one cationic surfactant, in particular in the case where it comprises an amphoteric foaming surfactant. The cationic surfactants that can be used according to the present invention are in particular the salts of primary, secondary or tertiary fatty amines, optionally polyoxyalkylenated, the quaternary ammonium salts, the imidazoline derivatives, the oxides of amines with a cationic nature, and their mixtures. . The quaternary ammonium salts are, for example: those which have the following general formula (IV): R 3 R 2 'R 4 (IV) X in which the radicals R 1 to R 4, which may be identical or different, represent an aliphatic radical, linear or branched, having from 1 to 30 carbon atoms, or an aromatic radical such as aryl or alkylaryl. The aliphatic radicals can comprise heteroatoms such as in particular oxygen, nitrogen, sulfur, halogens. The aliphatic radicals are, for example, chosen from alkyl, alkoxy, polyoxyalkylene (C 2 -C 6), alkylamide, (C 12 -C 22) alkylamido (C 2 -C 6) alkyl, (C 12 -C 22) alkyl acetate, hydroxyalkyl radicals, comprising about 1 to 30 carbon atoms; X is an anion chosen from the group of halides, phosphates, acetates, lactates, (C 2 -C 6) alkyl sulphates, alkyl-or-alkylarylsulphonates, R 1 and R 2 preferably denotes a C 1 -C 4 alkyl, or a C 1 -C 4 hydroxyalkyl; C4. the quaternary ammonium salts of imidazolinium, such as for example with the following formula (V): embedded image in which R 5 represents an alkenyl radical, or alkyl having from 8 to 30 carbon atoms, for example derived from coconut fatty acids, R 6 represents a hydrogen atom, a C 1 -C 4 alkyl radical or an alkenyl or alkyl radical containing from 8 to 30 carbon atoms, R 7 represents a C 1 -C 4 alkyl radical, R 8 represents a hydrogen atom, a C 1 -C 4 alkyl radical, X- is an anion chosen from the group of halides, phosphates, acetates, lactates, alkyl sulphates, alkyl-or- alkylarylsulfonates. Preferably, R 5 and R 6 denote a mixture of alkenyl or alkyl radicals containing from 12 to 21 carbon atoms, for example derived from tallow fatty acids; R7 is methyl, R8 is hydrogen. the quaternary diammonium salts of formula (VI): R ++ 2X, wherein R 9 denotes an aliphatic radical containing from about 16 to 30 carbon atoms; carbon, R10, R11, R12, R13 and R14, which are identical or different, are chosen from hydrogen or an alkyl radical containing from 1 to 4 carbon atoms, and X is an anion chosen from the group of halides, acetates and phosphates , nitrates and methylsulfates. the quaternary ammonium salts containing at least one ester function, for example those of formula (VII) below: (C 1 -C 12) R 18 C 11 R 17 C (O C N H 2 N N (C p H 2 O) 8 R 16 R 15 in which: - R 15 is chosen from C 1 -C 6 alkyl radicals and C 1 -C 6 hydroxyalkyl or dihydroxyalkyl radicals; R 16 is chosen from: O H - the radical R19 - C - linear or branched C 1 -C 22 hydrocarbon radicals R, saturated or unsaturated, - the hydrogen atom, - R18 is chosen from: o I - the radical R21 C - linear or branched, saturated or unsaturated C1-C6 hydrocarbon radicals R22 - the hydrogen atom, R17, R19 and R21, which are identical or different, are chosen from linear or branched, saturated or unsaturated C7-C21 hydrocarbon radicals; n, p and r, which may be identical or different, are integers ranging from 2 to 6; y is an integer ranging from 1 to 10; and x, which are identical or different, are integers ranging from 0 to 10; simple or complex, organic or inorganic; Provided that the sum x + y + z is from 1 to 15, that when x is 0 then R16 is R20 and when z is 0 then R18 is R22. The alkyl radicals R15 may be linear or branched and more particularly linear. Preferably R 15 denotes a methyl, ethyl, hydroxyethyl or dihydroxypropyl radical and more particularly a methyl or ethyl radical. Advantageously, the sum x + y + z is from 1 to 10. When R16 is a hydrocarbon radical R20, it may be long and have from 12 to 22 carbon atoms or short and have from 1 to 3 carbon atoms.

When R 18 is a hydrocarbon radical R 22, it preferably has 1 to 3 carbon atoms. Advantageously, R17, R19 and R21, which are identical or different, are chosen from linear or branched, saturated or unsaturated C 1 -C 21 hydrocarbon radicals, and more particularly from linear or branched C 11 -C 21 alkyl and alkenyl radicals. , saturated or unsaturated. Preferably, x and z, which are identical or different, are equal to 0 or 1. Advantageously, y is equal to 1. Preferably, n, p and r, identical or different, are equal to 2 or 3 and even more particularly are equal to 2. The anion is preferably a halide (chloride, bromide or iodide) or an alkyl sulphate more particularly methyl sulphate. However, it is possible to use methanesulphonate, phosphate, nitrate, tosylate, an anion derived from an organic acid such as acetate or lactate or any other anion compatible with ammonium with an ester function. The X- anion is even more particularly chloride or methylsulfate. More particularly, the ammonium salts of formula (VII) in which: R15 denotes a methyl or ethyl radical, - x and y are equal to 1; z is 0 or 1; n, p and r are 2; - R16 is chosen from: O - the radical R19 C - methyl, ethyl or C14-C22 hydrocarbon radicals - the hydrogen atom; - R18 is chosen from: 0 H - the radical R21-C - - the hydrogen atom; R17, R19 and R21, which are identical or different, are chosen from linear or branched, saturated or unsaturated C13-C17 hydrocarbon radicals and preferably from linear or branched, saturated or unsaturated C13-C17 alkyl and alkenyl radicals.

Advantageously, the hydrocarbon radicals are linear. Of the quaternary ammonium salts of formula (IV), tetraalkylammonium chlorides, for example dialkyldimethylammonium or alkyltrimethylammonium chlorides, in which the alkyl radical contains approximately from 12 to 22 carbon atoms, are preferred. , in particular behenyltrimethylammonium, distearyldimethylammonium, cetyltrimethylammonium, benzyldimethylstearylammonium chlorides or, on the other hand, palmitylamidopropyltrimethylammonium chloride or stearamidopropyldimethyl (myristylacetate) ammonium chloride sold under the name "CERAPHYL 70" by the company VAN DYK.

There may be mentioned, for example, the compounds of formula (V) such as the salts (in particular chloride or methyl sulphate) of diacyloxyethyl dimethyl ammonium, of diacyloxyethyl hydroxyethyl methyl ammonium, of monoacyloxyethyl dihydroxyethyl methyl ammonium, of triacyloxyethyl methyl ammonium, of monoacyloxyethyl hydroxyethyl dimethyl ammonium and their mixtures. The acyl radicals preferably have from 14 to 18 carbon atoms and come more particularly from a vegetable oil such as palm oil or sunflower oil. When the compound contains more than one acyl radical, the latter may be identical or different. These products are obtained for example by direct esterification of triethanolamine, triisopropanolamine, alkyldiethanolamine or alkyldiisopropanolamine, optionally oxyalkylenated on fatty acids or mixtures of fatty acids of plant or animal origin or by transesterification of their methyl esters. This esterification is followed by a quaternization using an alkylating agent such as an alkyl halide (preferably methyl or ethyl), a dialkyl sulphate (methyl or preferably ethyl), methyl methanesulphonate, methyl paratoluenesulfonate, glycol or glycerol chlorohydrin. Such compounds are for example sold under the names DEHYQUART by the company COGNIS, STEPANQUAT by the company STEPAN, NOXAMIUM by the company CECA, REWOQUAT WE 18 and REWOQUAT W75 by the company DEGUSSA. It is also possible to use the ammonium salts containing at least one ester function described in US-A-4874554 and US-A-4137180.

Quaternary diammonium salts of formula (VI) that are suitable for the invention include, in particular, propane diammonium dichloride. ADDITIVES The composition according to the invention may contain various water-soluble or liposoluble additives, chosen from those conventionally used in skincare or make-up products, insofar as these additives and their amounts do not adversely affect the qualities sought for the composition. according to the invention. The cleaning composition according to the present invention may thus comprise the following additives: cosurfactants; oil ; conservatives ; sequestering agents (EDTA and its salts); antioxidants; the perfumes ; dyestuffs; soluble dyes or pigments encapsulated or not; hydrophilic or lipophilic, anionic, nonionic, cationic or amphoteric polymers, thickeners or dispersants. The amounts of these various adjuvants are those conventionally used in the field under consideration, and for example from 0.01 to 20% by weight of the total weight of the composition. These adjuvants and their amounts must be such that they do not modify the desired property for the composition of the invention. The composition may further comprise a polymeric quaternary ammonium salt (distinct from the foregoing surfactants). These compounds are conditioning agents, that is to say that they make it possible to increase the amount of foam and to obtain a sensation of softness of comfort on the skin (maintenance of hydration). The polymeric quaternary ammonium salts are cationic or amphoteric polymers containing at least one quaternized nitrogen atom. As polymeric quaternary ammonium salts, there may be mentioned Polyquaternium (CTFA name), which provide softness and creaminess to the foaming cream. These polymers may be chosen preferably from the following polymers: polyquaternium such as the product MERQUAT 5 marketed by the company NALCO; Polyquaternium 6 such as the product SALCARE SC 30 marketed by the company CIBA, and the product MERQUAT 100 sold by the company NALCO; Polyquaternium 7 such as the MERQUAT S, MERQUAT 2200 and MERQUAT 550 products marketed by NALCO, and the SALCARE SC 10 product marketed by CIBA; Polyquaternium 10 such as the product Polymer JR400 sold by the company Amerchol; Polyquaternium 11 such as GAFQUAT 755, GAFQUAT 755N and GAFQUAT 734 products marketed by ISP; Polyquaternium 15 such as the product ROHAGIT KF 720 F marketed by the company ROHM; - Polyquaternium 16 such as the products LUVIQUAT FC905, LUVIQUAT FC370, LUVIQUAT HM552 and LUVIQUAT FC550 sold by the company BASF; Polyquaternium 22 such as the product MERQUAT 280 marketed by the company NALCO; Polyquaternium 28 such as the product STYLEZE CC10 sold by the company ISP; Polyquaternium 39 such as MERQUAT PLUS 3330 and MERQUAT 3330PR products marketed by NALCO; Polyquaternium 44 such as the LUVIQUAT CARE product marketed by BASF; Polyquaternium 46 such as the product LUVIQUAT HOLD marketed by BASF; Polyquaternium 47 such as the product MERQUAT 2001 marketed by the company NALCO. Preferably, the quaternary ammonium salts are selected from Polyquaternium-7, Polyquaternium-10, Polyquaternium-39, Polyquaternium-47, and mixtures thereof.

The polymeric quaternary ammonium salts may be in an amount (of active material) ranging for example from 0.01 to 5% by weight and better still from 0.05 to 1% by weight relative to the total weight of the composition. As an example of a particular conditioning agent, mention may be made of Polyquaternium-39, especially sold by Nalco under the names Merquat Plus 3330 and Merquat 3330PR. COMPOSITION The composition according to the present invention may especially be in the form of an aqueous composition thickened by means of the suspending agent described above. The composition according to the invention comprises an aqueous medium or aqueous phase, that is to say a medium comprising a quantity of water of at least 50% by weight, preferably ranging from 50 to 95% by weight and better from 60 to 90% by weight, relative to the total weight of the composition. The aqueous phase of the compositions according to the invention may contain, in addition to water, one or more solvents chosen from mono-alcohols having 1 to 6 carbon atoms, polyols and mixtures thereof. Mono-alcohols include, in particular, ethanol. As polyols, there may be mentioned glycerine; glycols such as butylene glycol, isoprene glycol, propylene glycol, polyethylene glycols such as PEG-8; sorbitol; sugars such as glucose, fructose, maltose, lactose, sucrose; and their mixtures. When they are present, the amount of monoalcohols and polyols in the composition of the invention may range, for example, from 0.01 to 30% by weight, preferably from 2 to 25% by weight and better still from 4 to 20% by weight, based on the total weight of the composition. Throughout the description, including the claims, the phrase "having one" should be understood as being synonymous with "having at least one", unless the opposite is specified. 30 The expressions "between ... and ..." and "from ... to ..." must be understood as including limits, unless the opposite is specified.

The following examples illustrate the present invention without limiting its scope. Example 1: Cleaning composition Quantities are indicated in percentage by weight. Phase Component ABC Comparative Composition Composition Composition of the Invention of the Invention A Water 10 Glycerine 5 5 Copolymer 2 of octylacrylamide / acrylates (1) 5 Al Crosslinked copolymer 6.87 6.87 6.87 of acrylates / vinylneodecanoate (2) B N-cocoyl glycinate sodium (3) 21.7 21.7 21.7 Coco betaine (4) 21.7 21.7 21.7 Salicylic acid 0.2 0.2 0.2 Phenoxyethanol 0.5 0.5 0.5 Chlorphenesin 0.25 0.25 0.25 Sodium benzoate 0.5 0.5 0.5 C PEG 14000 0.5 0.5 0.5 D Dilution 10% qsp pH = 6.4 qsp pH = 6.4 qsp pH = 6.4 E Polyquaternium-39 (5) 2 2 2 F Sodium chloride 0.6 0.6 0.6 Water 2.4 2.4 2.4 G Water 25.03 23.78 20.78 H Polyquaternium-6 (6) 0.75 TiO2 2 2 2 TOTAL 100 100 100 The following "MA" values indicate the active ingredient content of the commercial product under consideration. (1) Dermacryl 79 marketed by the company Akzo Nobel, 97% MA (2) Aculyn 38 Polymer sold by the company Rohm and Haas (Dow Chemical), 29% MA (3) amilite GCS-12K sold by the company Ajinomoto 30% MA (4) EMPIGEN BB / FL marketed by the company HUNTSMAN 30% MA (5) MERQUAT 3330PR marketed by the company NALCO 9.25% MA 10 (6) MERQUAT 100 marketed by the company NALCO 40% Implementation 1- Heated A at 80 ° C under Rayneri. 2- Al is poured into A slowly. 3- Neutralized with potassium hydroxide until the gel is swollen. 4- Phase B is prepared and then placed in a water bath at 85 ° C. 5- Pour phase B into phase A. 6- Sprinkle C always under Rayneri. 7- Leave 10 minutes. 8. The correct pH is brought to D. 9- Cool in a cold water bath at 25 ° C. 10-E is added cold under Rayneri. 11- We leave 5 minutes. 12 Adding F. 13. Adding G. 14 Adding H. 15 Add I. Composition A is the reference. It contains polyquaternium-6 or PQ6 whose chemical name is polydimethyl di allyl ammonium chloride) polymer of molecular weight 150 000 g / mol, conditioner frequently encountered in foaming bases and known to be a very good deposition agent (or agent prodéposant) thanks to its high charge density of 6.2 meq / g. Compositions B and C contain dermacyl 79 respectively at 2% and 5% MA. It should be noted that like any polymer with acidic carboxylic groups, the acrylates need to be neutralized with a suitable base such as potassium hydroxide. By neutralizing the acidic carboxylic groups, the polymer becomes soluble in water.

Example 2: Comparison of Foaming Performance Protocol The three formulas are tested under the following conditions: The experimenter takes 1 g of product on wet hands. He applies shearing 10 times, estimates the mixture with water, covering the film, starting foam on a scale of 1 to 10. Then he adds 2 ml of water and makes 10 turns in his hand to generate the foam. He then notes the volume of foam, the size of the bubbles, the density of foam. He repeats once and then notes the ease of rinsing.

Results 3 people evaluated each of the three products one after the other. ABC Water mix 8 6 5 Cover 10 10 10 Start 8 8 6 Foam volume 8 9 9 Bubble size 3 2 1 Foam density 7 8 9 Rinse 9 9 9 Product C, containing 5% by weight of a water-insoluble polymer of the acrylate / alkylacrylamide copolymer type (Dermacryl 79) gives a more present, smoother, thinner and denser foam than the product B containing 2% by weight of Dermacryl 79 which gives a more present foam , more creamy, thinner and denser than the product A. Example 3: Characterization SEM of the deposit Protocol 40 p.1 foaming product are applied directly on a surface 2x2cm2 of wet skin on the forearm. Foam a few seconds by rotating on the defined area. It is rinsed under controlled flow water for 30s. At the end, this corresponds to a deposited quantity of 1000 mg / 100 cm 2.

The skin is then gently dried by tapping with a hairless wipe. Skin impressions are performed in two stages: Silflo imprint, then Araldite counterprint. The counterprints are then directly observed by scanning electron microscopy (SEM). (references of the apparatus: MEB JEOL JSM-3I0F) Results The SEM observations of the amilite / betaine gels A and B based on 2% of TiO2 give us the images provided in the appendix (FIG. 1): The Dermacryl shows a deposit more homogeneous polymer on the one hand and more particles of TiO2 deposited on the other hand. Example 4: Quantification X-ray fluorescence Protocol 25 Measurements are made with PANalytical spectrophotometer PW4030 X-ray Spectrometer - (ED-XRF, energy dispersive X-ray fluorescence spectrometry) Setting: Voltage 15kV, Intensity 58011A - no filter This The method conventionally used to illustrate the presence of impurities in the products has been adapted to quantify the deposits of mineral particles and in particular TiO 2 particles on the skin. The method consists of measuring the diffracted intensity of an RX source on a skin stripping performed after application / rinsing of the foaming agent. Here results are given diffracted intensity, proportional to the amount of TiO2 deposited, in counts per second (cps). To ensure that all the particles left on the skin are recovered, 5 successive strips are made after cleaning the forearm, applying them one by one for 30 seconds under the pressure of a weight of 180 g. We sum all the intensities measured on each of them. The test is repeated twice for an average. In this example, the amount of Polyquaternium-6 introduced into the composition corresponds to an amount usually present in a cleaning product.

Results Example Nature of Adhesion Agent Diffracted Intensity (cps) A Polyquatemium-6 (0.75%) 15 ± 8 B Dermacryl 79 (2%) 12 ± 1.5 C Dermacryl 79 (5%) 93 ± 33 It is evident from this test that the amount of TiO 2 particles deposited via the composition according to the present invention is greater than the amount of TiO 2 particles deposited via the comparative composition when the amount of Dermacryl 79 is sufficient (5% by weight). weight). EXAMPLE 5 In Vivo Evaluation of the Deposition Test Protocol 20 Beauticians evaluate the brightness, the powdery effect, the lightening, the homogeneity of the complexion, the visibility of the enlarged pores, the attenuation of the redness and the striations of the face on 6 models after cleansing the face in half-face under controlled conditions (300mg of product applied per half-face) with foaming. Example Deposition agents evaluated Immediate effects Aesthetic flashes A Polyquatemium-6 (0.75%) Powdered finish and attenuation of dehydration streaks Example Deposition agents evaluated Immediate effects Aesthetic flashes B Dermacryl 79 (2%) The most effective of the formulas on redness, pore dilation and homogeneity of the complexion The foaming gel according to the invention (example B) is more efficient than the comparative composition (example A), significant effects are noted.

Claims (14)

REVENDICATIONS1. Cosmetic cleansing composition foaming rinse comprising, in a physiologically acceptable medium: a surfactant system with an active material content greater than or equal to 3% by weight, relative to the total weight of the composition, at least one suspending agent, at least a cosmetic additive, and at least one water-insoluble, copolymer-type, film-forming polymer having at least one monomer unit of the acrylate type, said polymer particles having a primary size greater than 500 nm. 2. Cosmetic composition according to claim 1, wherein said at least one film-forming polymer has a glass transition temperature (Tg) less than or equal to 10 ° C. 15 3. Cosmetic composition according to claim 1 or 2, wherein said at least one film-forming polymer has a self-adhesive such that the tensile force (Fmax in Newton (N)) necessary to separate two coated surfaces of said polymer, is greater than 1 N and preferably greater than 3 N. 4. The cosmetic composition as claimed in any one of the preceding claims, wherein said at least one film-forming polymer has a weight average molar mass of between 50,000 and 200,000 g / mol, more particularly between 100,000 and 200,000 g / mol. mol, even more preferentially 110 000 and 180 000 g / mol. 5. Cosmetic composition according to any one of the preceding claims, wherein said at least one film-forming polymer comprises at least one monomeric unit of alkylacrylamide type. Cosmetic composition according to any one of the preceding claims, wherein said at least one film-forming polymer comprises at least the following two monomeric units represented by the general formulas (A) and (B) CO2Ri (C 2 H 2 H 2 O) (B) wherein R1, R2 and R3 are represented by a hydrogen atom or a (C1-C50) alkyl group, preferably (C1-C20) alkyl, preferably said polymer comprising at least the following three monomeric units represented by the general formulas (A), (B) and (C): CO2Ri (A) H2 2 C * H2 CI 0211 (C) * (* H2 (B) in which R1, R2 and R3 are represented by an atom hydrogen or a group (Ci-050) alkyl, preferably (Ci-C20) alkyl. 7. Cosmetic composition according to any one of the preceding claims, wherein said at least one film-forming polymer is of the acrylate (s) / octylacrylamide copolymer type, said at least one film-forming polymer may comprise at least the two following monomeric units represented by the general formulas (A) and (B '): wherein R1 and R2 are represented by a hydrogen atom or a (C1-C50) alkyl group, preferably (C1-C20) ), preferably, said polymer comprising at least the following three monomeric units represented by the general formulas (A), (B ') and (C): O (A) H 2 (B') CO 2 H 2 CH 3 H 3 C CH 3 CH 2 Embedded image in which R 1 and R 2 are represented by a hydrogen atom or a (C 1 -C 50) alkyl group, preferably (C 1 -C 4); C20) alkyl. 8. Cosmetic composition according to any one of claims 1 to 4, wherein said at least one film-forming polymer is a copolymer consisting of at least two monomeric units of different acrylate type. 9. Cosmetic composition according to any one of the preceding claims, wherein said at least one film-forming polymer is included in an active ingredient content ranging from 0.1 to 20% by weight, in particular from 0.1 to 5% by weight. weight, relative to the total weight of the composition. 10. Cosmetic composition according to any one of the preceding claims, wherein the surfactant system comprises at least one foaming surfactant chosen from foaming surfactants anionic, amphoteric (or zwitterionic), nonionic and / or cationic and mixtures thereof, said anionic surfactant. being in particular chosen from anionic derivatives of proteins of plant origin or silk proteins, phosphates and alkylphosphates, carboxylates, sulphosuccinates, amino acid derivatives, alkyl sulphates, alkyl ether sulphates, sulphonates, isethionates , taurates, alkyl sulphoacetates, polypeptides, anionic derivatives of alkyl polyglucoside, soaps (salts of fatty acids) and mixtures thereof, more particularly, among alkyl sulphates, alkyl ether sulphates, isethionates, derivatives of amino acids, and mixtures thereof, said amphoteric or zwitterionic surfactant being articulier chosen from betaines, N-alkylamidobétaines and their derivatives, sultaines, alkyl polyaminocarboxylates, alkylamphoacétates and their mixtures, more particularly from betaines, alkylamphoacétates and their mixtures, said nonionic surfactant being in particular chosen from alkyls polyglucosides (APG), oxyalkylenated glycerol esters, oxyalkylenated sugar esters, and mixtures thereof, more particularly from APGs, said cationic surfactant being in particular chosen from salts of primary, secondary or tertiary fatty amines, optionally polyoxyalkylenated; quaternary ammonium salts, imidazoline derivatives, cationic amine oxides, and mixtures thereof. A cosmetic composition according to any of the preceding claims, wherein the suspending agent is selected from a naturally occurring suspending agent such as xanthan, carrageenan, guar and starch or a suspending agent. of synthetic origin, the suspending agent may be included in said composition in an active material content of between 0.1 and 10% by weight, in particular between 0.1 and 2.5% by weight, relative to total weight of the composition. 12. Cosmetic composition according to any one of the preceding claims, in which the one or more cosmetic additives are chosen from particles, fibers and / or active ingredients and mixtures thereof, the said particles being in particular chosen from: organic pigments, in particular carbon black, D & C type pigments, and lacquers based on cochineal carmine, barium, strontium, calcium, aluminum, inorganic pigments such as: o titanium oxide, zinc oxide, colored iron oxide, o alumina, o pearls, o carbonates, o ceramic particles such as boron nitride, o diamond / graphite, o magnesia, o glass as for example boro- and phosphosilicate, o silica, for example amorphous silica, colloidal, precipitated, fumed, natural or in the form of silica-gels, o clay such as for example monmorionite, o zirconium and sulphate of barium, where silicates for example, talc, illite, kaolin, zeolite, sepiolite, laponite, hectorite, bentonite or mica, or Lionite PC particles marketed by Lion Corporation based on silica, ZnO , A1203 and TiO2, - polymer particles such as, for example, polymethyl methacrylate (PMMA), polytetrafluoroethylene (PTFE), polyamide, polyacrylate or copolymers thereof, - wax particles such as carnauba wax, - inorganic sunscreen particles such as TiO 2, perlite particles, silica airgel particles, and mixtures thereof; said active agents being chosen from vitamins, such as vitamins A, B3, PP, B5, E, K1 and / or C and the derivatives of these vitamins and in particular their esters; keratolytic or prodesquamants agents, in particular hydroxy acids, hydroxy acids, keto acids, ketoacids, retinoids and their esters, retinal, retinoic acid and its derivatives; plant extracts such as extracts of small holly and / or horse chestnut; xanthine bases such as caffeine; anti-free radical agents; organic or inorganic sunscreens; moisturizing agents such as polyols; ceramides; DHEA and its derivatives; coenzyme Q10; bleaching and depigmenting agents by biological action such as kojic acid, extracts of skullcap, mulberry, licorice and / or chamomile; para-aminophenol derivatives, arbutin and derivatives thereof, bacterial anti-adhesion active agents such as salicylic acid and capryloylsalicylic acid, and mixtures thereof, the antiseborrhoeic active agents chosen from vitamins B3 and B5; zinc salts, and in particular zinc oxide and zinc gluconate; salicylic acid and its derivatives such as n-octanoyl-5-salicylic acid; triclosan; capryloylglycine; an extract of clove; octopirox; hexamidine; azelaic acid and its derivatives; and said fibers being selected from polyamide or nylon fibers, polyaramid, viscose, cotton, polyacrylic, polyvinyl acetate or PVA or composite fibers. 13. Cosmetic composition according to any one of the preceding claims, wherein said at least one cosmetic additive is included in the composition in an active ingredient content of between 0.1 and 10% by weight, in particular between 0.1 and 5% by weight. % by weight, relative to the total weight of the composition. 14. A method of cleaning keratin materials comprising applying to said keratinous materials a composition according to any one of the preceding claims, to foam said composition and then rinsing said composition.